What makes non-antibody scaffolds a strategic alternative?

While monoclonal antibodies are the current gold standard, they are large, complex, and difficult to manufacture. Non-antibody scaffolds, such as Affibodies and DARPins, are smaller, more stable, and can be engineered to bind to targets that antibodies cannot reach. For B2B buyers, these offer a pathway to lower production costs and improved tissue penetration.

Is the Synthetic Biology Market Growth sustainable through 2025?

The Synthetic Biology Market Growth is underpinned by the modularity of these new scaffolds. In 2024, the focus is on "plug-and-play" protein engineering, where various functional domains can be swapped in and out of a standard scaffold to create multi-functional proteins. By 2025, this modular approach will be the primary method for creating targeted imaging agents and localized diagnostics.

The economic case for modular protein design

By reusing a validated scaffold for multiple products, companies can significantly lower the regulatory risk and development time for subsequent drugs in their pipeline. This "platform approach" is highly favored by venture capital firms looking for high-efficiency biotech investments.

  • Superior thermal and chemical stability compared to antibodies.
  • Lower immunogenicity risks in chronic dosing scenarios.
  • Ease of production in simpler, microbial host systems.

2024/2025 Outlook

As we enter 2025, we anticipate the first wave of scaffold-based therapeutics to enter Phase III trials. The success of these trials will trigger a massive shift in how biopharma companies allocate their engineering resources away from traditional IgGs.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com